All Editorials articles – Page 19
- 
      
        
      
      
     - 
      
        
      
      OpinionDo chemists spend enough time in the lab?
The secret to a career in academia could be finding the right work–work balance
 - 
      
        
      
      OpinionUncertainty around Trump presidency is harmful to industry
Uncertainty is anathema to industry. Trump and Brexit are frustrations, but the wheels do not stop.
 - 
      
        
      
      OpinionRegulatory tightropes
When lobbying and marketing clash with scientific evidence, regulators walk a fine line
 - 
      
        
      
      OpinionShould chemistry degrees require A-level maths?
Requiring a maths qualification could deprive the profession of fresh talent
 - 
      
        
      
      
     - 
      
        
      
      OpinionA nanocarbon revolution
Twenty years on from the Nobel prize for fullerenes chemists pay tribute to the field Harry Kroto helped to launch
 - 
      
        
      
      OpinionYou don’t get me, I’m part of the union
Graduate student unions have power for now, but it may not last
 - 
      
        
      
      OpinionWill US politics Trump science?
As America seeks a new president, science hangs in the balance
 - 
      
        
      
      OpinionBooster shot
Zika and Ebola have highlighted the pharmaceutical industry’s ability to respond to critical needs
 - 
      
        
      
      
     - 
      
        
      
      
     - 
      
        
      
      
     - 
      
        
      
      OpinionFilling up on chemistry at ACS Philly
Philadelphia welcomes 13,000 chemical scientists for ACS national meeting
 - 
      
        
      
      OpinionHow do companies deal with political shifts?
Political instability hits small companies hardest
 - 
      
        
      
      OpinionHow your name affects your career
Kate Granger showed few things have such impact as introducing yourself
 - 
      
        
      
      OpinionA new source of helium is good news for science
Success prospecting for helium shouldn’t halt efforts to conserve and recover this vital scientific resource
 - 
      
        
      
      
     - 
      
        
      
      
     - 
      
        
      
      OpinionTime for better incentives to keep drug costs low
Getting outraged at drug price hikes is all very well, but we need more constructive options